Nazione: Irlanda
Lingua: inglese
Fonte: HPRA (Health Products Regulatory Authority)
LANSOPRAZOLE
Teva Pharma B.V.
LANSOPRAZOLE
15 Milligram
Capsules Gastro-Resistant
Product subject to prescription which may be renewed (B)
Withdrawn
2014-01-20
PACKAGE LEAFLET: INFORMATION FOR THE USER BYLANS 15MG GASTRO-RESISTANT CAPSULES BYLANS 30MG GASTRO-RESISTANT CAPSULES (LANSOPRAZOLE) READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. • If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. IN THIS LEAFLET: 1. What Bylans Gastro-resistant Capsules are and what they are used for 2. Before you take Bylans Gastro-resistant Capsules 3. How to take Bylans Gastro-resistant Capsules 4. Possible side effects 5. How to store Bylans Gastro-resistant Capsules 6. Further information 1. WHAT BYLANS GASTRO-RESISTANT CAPSULES ARE AND WHAT THEY ARE USED FOR Lansoprazole belongs to a group of medicines called proton pump inhibitors. Proton pump inhibitors like lansoprazole, reduce the amount of acid that your stomach makes. You have been given lansoprazole, because you have a condition caused by stomach acid. Your doctor may prescribe Lansoprazole for: • Treatment of ulcers in your stomach or duodenum • Treatment or prevention of inflammation in your oesophagus (gullet). This is called Gastroesophageal Reflux Disease • Treatment of infection caused by the bacteria _Helicobacter pylori_ together with suitable antibiotics in the treatment of ulcers in the stomach or duodenum (eradication therapy) • Relieving you from the unpleasant symptoms that often occur with these conditions • Stopping these conditions coming back. • Treatment or prevention of ulcers in stomach or duodenum in patients requiring continued NSAID treatment (NSAID treatment is used against pain or inflammation). • Treatment of heartburn and acid regurgitation. • Lansoprazole is sometimes given t Leggi il documento completo
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT ByLans 15 mg Gastro-resistant Capsules 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule contains lansoprazole, 15 mg Excipients: Each capsule contains 64.8 mg sucrose (in sugar spheres) For a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Gastro-resistant capsule, hard. Size 3, white cap marked with ‘L’ and white body marked with ‘15’, containing white to beige gastro-resistant micropellets. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment of duodenal and/or benign gastric ulcer Treatment and prophylaxis of reflux oesophagitis Symptomatic Gastroesophageal Reflux Disease (GORD). Treatment and prophylaxis of NSAID-associated benign gastric ulcers, duodenal ulcers and relief of symptoms in patients requiring continued NSAID treatment. Treatment of Zollinger-Ellison syndrome. Eradication of _Helicobacter pylori _concurrently given with appropriate antibiotic therapy and prevention of relapse of peptic ulcers in patients with _H.pylori _associated ulcers 4.2 POSOLOGY AND METHOD OF ADMINISTRATION For optimal effect, lansoprazole should be taken once daily in the morning, except when used for H. pylori eradication when treatment should be twice a day, once in the morning and once in the evening. Lansoprazole should be taken at least 30 minutes before food (see section 5.2). Capsules should be swallowed whole with liquid. The capsules should be swallowed whole. Do not crush or chew. Dosage: Treatment of duodenal ulcer: the recommended dose is lansoprazole 30 mg once daily for 2 weeks. In patients not fully healed within this time, the medication is continued at the same dose for another two weeks. Treatment of benign gastric ulcer: the recommended dose is lansoprazole 30 mg once daily Leggi il documento completo